Arkolith/Insider Trading/ORTX/Form 4

Thomas Frank E

See RemarksOrchard Therapeutics plc (ORTX) · full profile →Form 4 · filed Jan 24, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
11
1 non-derivative · 10 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 24, 2024Disposed to issuer(D)92K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 24, 2024Disposed to issuer(D)200K—$00
Jan 24, 2024Disposed to issuer(D)179K—$00
Jan 24, 2024Disposed to issuer(D)406K—$00
Jan 24, 2024Disposed to issuer(D)75K—$00
Jan 24, 2024Disposed to issuer(D)458K—$00
Jan 24, 2024Disposed to issuer(D)335K—$00
Jan 24, 2024Disposed to issuer(D)28K—$00
Jan 24, 2024Disposed to issuer(D)100K—$00
Jan 24, 2024Disposed to issuer(D)150K—$00
Jan 24, 2024Disposed to issuer(D)310K—$00

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-007078) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML